First Time Loading...

Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT

Watchlist Manager
Arcturus Therapeutics Holdings Inc Logo
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Watchlist
Price: 29.78 USD -2.36% Market Closed
Updated: May 20, 2024

Arcturus Therapeutics Holdings Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arcturus Therapeutics Holdings Inc
Total Current Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Total Current Liabilities
$115.4m
CAGR 3-Years
29%
CAGR 5-Years
51%
CAGR 10-Years
43%
Abbvie Inc
NYSE:ABBV
Total Current Liabilities
$41.5B
CAGR 3-Years
9%
CAGR 5-Years
24%
CAGR 10-Years
21%
Gilead Sciences Inc
NASDAQ:GILD
Total Current Liabilities
$13B
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
8%
Amgen Inc
NASDAQ:AMGN
Total Current Liabilities
$19.7B
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
9%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Current Liabilities
$3.8B
CAGR 3-Years
25%
CAGR 5-Years
28%
CAGR 10-Years
26%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Current Liabilities
$3.6B
CAGR 3-Years
4%
CAGR 5-Years
19%
CAGR 10-Years
28%

See Also

What is Arcturus Therapeutics Holdings Inc's Total Current Liabilities?
Total Current Liabilities
115.4m USD

Based on the financial report for Mar 31, 2024, Arcturus Therapeutics Holdings Inc's Total Current Liabilities amounts to 115.4m USD.

What is Arcturus Therapeutics Holdings Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
43%

Over the last year, the Total Current Liabilities growth was 28%. The average annual Total Current Liabilities growth rates for Arcturus Therapeutics Holdings Inc have been 29% over the past three years , 51% over the past five years , and 43% over the past ten years .